Pneumococcal polysaccharide vaccine, 23-valent, adult or immunosuppressed patient?dosage, for use in individuals 2 years or older, for subcutaneous or intramuscular use;
CPT Drug Code
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
Pneumovax 23 is a Vaccine-Pneumococcal drug manufactured by Merck and administered via the Injection route of administration. The CPT Drug Code: 90732 is aligned to the drug Pneumovax 23.
Pneumovax 23 is a Pneumococcal vaccine for active immunization. It is used to prevent pneumococcal disease caused by the 23 serotypes contained in the vaccine. Pneumococcal disease is any illness that is caused by pneumococcal bacteria. Pneumococcal bacteria are one of the most common causes of pneumonia, but the bacteria can also cause ear infections, sinus infections, meningitis, bacteremia. Children under 2, adults 65 and older, those with certain pre-existing conditions, and cigarette smokers have elevated risks of pneumococcal disease.